Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation

作者: J. R. Wangen , L. Eidenschink Brodersen , T. T. Stolk , D. A. Wells , M. R. Loken

DOI: 10.1111/IJLH.12151

关键词:

摘要: Summary Introduction The extension of quantitative flow cytometric studies to the erythroid lineage in patients with suspected myelodysplastic syndrome has prompted a reassessment cell surface antigen expression during normal erythropoiesis. Erythropoiesis and pathologic bone marrows was studied determine expected antigenic relationships maturing cells. Methods A total 200 marrow specimens were evaluated by multidimensional cytometry (MDF). Samples prepared using either NH4Cl lysis or Ficoll density gradient separation. Results Normal development is described as two-step process observable intensity between CD235a, CD71, CD45, CD105, CD34, CD117, CD36. The variability these intensities (CV) determined. A comparison processing techniques determined optimal analytic technique for analysis early-stage cells. Nucleic acid staining DRAQ5 revealed that allows reticulocytes mature erythrocytes otherwise eliminated lysis. Conclusion These data demonstrate while alters light scatter characteristics precursors, it did not alter nucleic content. defined. These provide basis individuals those dysplasia associated syndromes.

参考文章(22)
MR Loken, VO Shah, KL Dattilio, CI Civin, Flow cytometric analysis of human bone marrow: I. Normal erythroid development Blood. ,vol. 69, pp. 255- 263 ,(1987) , 10.1182/BLOOD.V69.1.255.255
Luca Malcovati, MATTEO GIOVANNI Della Porta, M Lunghi, C Pascutto, L Vanelli, E Travaglino, M Maffioli, Paolo Bernasconi, Mario Lazzarino, Rosangela Invernizzi, Mario Cazzola, None, Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia. ,vol. 19, pp. 776- 783 ,(2005) , 10.1038/SJ.LEU.2403680
M G Della Porta, L Malcovati, R Invernizzi, E Travaglino, C Pascutto, M Maffioli, A Gallì, S Boggi, D Pietra, L Vanelli, C Marseglia, S Levi, P Arosio, M Lazzarino, M Cazzola, Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome Leukemia. ,vol. 20, pp. 549- 555 ,(2006) , 10.1038/SJ.LEU.2404142
Robert W. Allan, M.A. Ansari-Lari, Sandra Jordan, DRAQ5-based, no-lyse, no-wash bone marrow aspirate evaluation by flow cytometry. American Journal of Clinical Pathology. ,vol. 129, pp. 706- 713 ,(2008) , 10.1309/D2M6Q7BYHWAM1FYQ
Arjan A. van de Loosdrecht, Theresia M. Westers, August H. Westra, Angelika M. Dräger, Vincent H. J. van der Velden, Gert J. Ossenkoppele, Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood. ,vol. 111, pp. 1067- 1077 ,(2008) , 10.1182/BLOOD-2007-07-098764
Matteo Giovanni Della Porta, Francesco Lanza, Luigi Del Vecchio, , Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. Cytometry Part B-clinical Cytometry. ,vol. 80, pp. 201- 211 ,(2011) , 10.1002/CYTO.B.20607
Sergio Matarraz, Carlos Fernandez, Manuel Albors, Cristina Teodosio, Antonio López, María Jara-Acevedo, Carlos Cervero, Gonzalo Caballero, Oliver Gutierrez, Alberto Orfao, Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: a frame of reference for the study of dysplastic hematopoiesis. Cytometry Part B-clinical Cytometry. ,vol. 80, pp. 354- 361 ,(2011) , 10.1002/CYTO.B.20605
Maryalice Stetler-Stevenson, Diane C. Arthur, Nicholas Jabbour, Xiu Y. Xie, Jeff Molldrem, A. John Barrett, David Venzon, Margaret E. Rick, Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome Blood. ,vol. 98, pp. 979- 987 ,(2001) , 10.1182/BLOOD.V98.4.979
S Machherndl-Spandl, S Suessner, M Danzer, J Proell, C Gabriel, J Lauf, R Sylie, HU Klein, MC Béné, A Weltermann, P Bettelheim, None, Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling Blood Cancer Journal. ,vol. 3, ,(2013) , 10.1038/BCJ.2012.45
Bart L. Scott, Denise A. Wells, Michael R. Loken, David Myerson, Wendy M. Leisenring, H. Joachim Deeg, Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome. Blood. ,vol. 112, pp. 2681- 2686 ,(2008) , 10.1182/BLOOD-2008-05-153700